Karen S. Lynch

Karen S. Lynch is a declared insider at 4 companies (chief executive); the most frequent names are CVS HEALTH Corp, Aetna Inc /PA/ and Thermo Fisher Scientific Inc. Between 1 February 2016 and 12 November 2025, the trades on record add up to 13 filings.

Purchases make up the whole of the open-market record (1 purchase, €882k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 11 share grants and 1 option exercise.

The latest filing, published on 14 November 2025, reports a share grant in Automatic Data Processing Inc. The last insider purchase was made public on 5 May 2023, 1,262 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.